Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma

This cohort study examines the clinical efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced malignant peritoneal mesothelioma.

Detalles Bibliográficos
Autores principales: Raghav, Kanwal, Liu, Suyu, Overman, Michael, Morani, Ajaykumar, Willette, Anneleis, Fournier, Keith, Varadhachary, Gauri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346939/
https://www.ncbi.nlm.nih.gov/pubmed/34357397
http://dx.doi.org/10.1001/jamanetworkopen.2021.19934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346939/
https://www.ncbi.nlm.nih.gov/pubmed/34357397
http://dx.doi.org/10.1001/jamanetworkopen.2021.19934

Ejemplares similares